Home › Trial NCT00039325
Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
- Trial IDNCT00039325
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorJonsson Comprehensive Cancer Center
- Enrollment28
- Start date2002-03
- ConditionsMelanoma (Skin)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.